Navegar por término MeSH "Double-Blind Method"

Mostrando ítems 1-10 de 10

Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

2019- Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; Bregeault, M. F.; [et al.]
Effect of allopurinol in addition to hypothermia treatment in neonates for hypoxic-ischemic brain injury on neurocognitive outcome (ALBINO): study protocol of a blinded randomized placebo-controlled parallel group multicenter trial for superiority (phase III)

2019- Maiwald, C. A.; Annink, K. V.; Rudiger, M.; Benders, Mjnl; van Bel, F.; [et al.]
Effect of antiseptic gels in the microbiologic colonization of the suture threads after oral surgery

2020- Rodríguez Zorrilla, S.; Blanco Carrión, A.; García García, Abel; Galindo Moreno, P.; Marichalar Mendía, X.; [et al.]
Effectiveness of steroids versus placebo in preventing upper airway obstruction after extubation in critically ill children: rationale and design of a multicentric, double-blind, randomized study

2020- Manrique, G.; Butragueno-Laiseca, L.; Gonzalez, R.; Rey, C.; de Companon, Z. M.; [et al.]
Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial

2019- White, H. D.; Steg, P. G.; Szarek, M.; Bhatt, D. L.; Bittner, V. A.; [et al.]
Efficacy and safety of once-monthly efpeglenatide in patients with type 2 diabetes: Results of a phase 2 placebo-controlled, 16-week randomized dose-finding study

2020- Del Prato, S; Kang, JH; Trautmann, ME; Stewart, J; Sorli, CH; [et al.]
Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study

2020- Martinón Torres, Federico; Rusch, S.; Huntjens, D.; Remmerie, B.; Vingerhoets, J.; [et al.]
Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial

2020- Torrecilla, C.; Fernández-Concha, J.; Cansino, J. R.; Mainez, J. A.; Amón, J. H.; [et al.]
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety

2020- Markman, J. D.; Bolash, R. B.; McAlindon, T. E.; Kivitz, A. J.; POMBO SUAREZ, MANUEL ENRIQUE; [et al.]
The safety and efficacy of the tetanus vaccine intramuscularly versus subcutaneously in anticoagulated patients: a randomized clinical trial

2014- Lago-Deibe, Fernando I.; Martin-Miguel, Maria-Victoria; Velicia-Penas, Carmen; Rey Gomez-Serranillos, Isabel; Fontanillo-Fontanillo, Manuela [et al.]